Effect of dexamethasone treatment at variable therapeutic windows in reversing nitrogen mustard-induced corneal injuries in rabbit ocular in vivo model-Reference-Cited by-同舟云学术

Effect of dexamethasone treatment at variable therapeutic windows in reversing nitrogen mustard-induced corneal injuries in rabbit ocular in vivo model

Published:2022-02 Issue: Volume:437 Page:115904
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Goswami Dinesh G.,Mishra Neha,Kant Rama,Agarwal Chapla,Ammar David A.,Petrash J. Mark,Tewari-Singh Neera,Agarwal Rajesh

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference52 articles.

1. Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits;Amir;J. Appl. Toxicol.,2000

2. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans;Balali-Mood;Basic Clin. Pharmacol. Toxicol.,2006

3. Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard;Banin;Invest. Ophthalmol. Vis. Sci.,2003

4. The role of vascular endothelial growth factor in wound healing;Bao;J. Surg. Res.,2009

5. The role of neuroinflammation in Parkinson’s disease;Chen;Neuroinflammation,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dexamethasone sodium phosphate loaded nanoparticles for prevention of nitrogen mustard induced corneal injury;Experimental Eye Research;2024-06

2. Chloropicrin induced ocular injury: Biomarkers, potential mechanisms, and treatments;Toxicology Letters;2024-05

3. Dexamethasone targets actin cytoskeleton signaling and inflammatory mediators to reverse sulfur mustard-induced toxicity in rabbit corneas;Toxicology and Applied Pharmacology;2024-02

4. Mouse Model of Nitrogen Mustard Ocular Surface Injury Characterization and Sphingolipid Signaling;International Journal of Molecular Sciences;2024-01-06

5. Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial;British Journal of Ophthalmology;2023-11-28